Silverfin false false 31/12/2025 01/01/2025 31/12/2025 Elizabeth Anne Taylor 17/12/2009 Robert Horace Taylor 17/12/2009 10 September 2026 The principal activity of the company during the year was the provision of medical services. 07107868 2025-12-31 07107868 bus:Director1 2025-12-31 07107868 bus:Director2 2025-12-31 07107868 2024-12-31 07107868 core:CurrentFinancialInstruments 2025-12-31 07107868 core:CurrentFinancialInstruments 2024-12-31 07107868 core:ShareCapital 2025-12-31 07107868 core:ShareCapital 2024-12-31 07107868 core:RetainedEarningsAccumulatedLosses 2025-12-31 07107868 core:RetainedEarningsAccumulatedLosses 2024-12-31 07107868 core:OtherPropertyPlantEquipment 2024-12-31 07107868 core:OtherPropertyPlantEquipment 2025-12-31 07107868 bus:OrdinaryShareClass1 2025-12-31 07107868 bus:OrdinaryShareClass2 2025-12-31 07107868 bus:OrdinaryShareClass3 2025-12-31 07107868 bus:OrdinaryShareClass4 2025-12-31 07107868 bus:OrdinaryShareClass5 2025-12-31 07107868 2025-01-01 2025-12-31 07107868 bus:FilletedAccounts 2025-01-01 2025-12-31 07107868 bus:SmallEntities 2025-01-01 2025-12-31 07107868 bus:AuditExemptWithAccountantsReport 2025-01-01 2025-12-31 07107868 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 07107868 bus:Director1 2025-01-01 2025-12-31 07107868 bus:Director2 2025-01-01 2025-12-31 07107868 core:OtherPropertyPlantEquipment core:TopRangeValue 2025-01-01 2025-12-31 07107868 2024-01-01 2024-12-31 07107868 core:OtherPropertyPlantEquipment 2025-01-01 2025-12-31 07107868 bus:OrdinaryShareClass1 2025-01-01 2025-12-31 07107868 bus:OrdinaryShareClass1 2024-01-01 2024-12-31 07107868 bus:OrdinaryShareClass2 2025-01-01 2025-12-31 07107868 bus:OrdinaryShareClass2 2024-01-01 2024-12-31 07107868 bus:OrdinaryShareClass3 2025-01-01 2025-12-31 07107868 bus:OrdinaryShareClass3 2024-01-01 2024-12-31 07107868 bus:OrdinaryShareClass4 2025-01-01 2025-12-31 07107868 bus:OrdinaryShareClass4 2024-01-01 2024-12-31 07107868 bus:OrdinaryShareClass5 2025-01-01 2025-12-31 07107868 bus:OrdinaryShareClass5 2024-01-01 2024-12-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: 07107868 (England and Wales)

BLIJA LTD

Unaudited Financial Statements
For the financial year ended 31 December 2025
Pages for filing with the registrar

BLIJA LTD

Unaudited Financial Statements

For the financial year ended 31 December 2025

Contents

BLIJA LTD

COMPANY INFORMATION

For the financial year ended 31 December 2025
BLIJA LTD

COMPANY INFORMATION (continued)

For the financial year ended 31 December 2025
DIRECTORS Elizabeth Anne Taylor
Robert Horace Taylor
REGISTERED OFFICE 36 The Village
Haxby
York
YO32 3HT
United Kingdom
COMPANY NUMBER 07107868 (England and Wales)
ACCOUNTANT IWC Professional Ltd
Chartered Certified Accountants
Wellington House
Aviator Court
York
YO30 4UZ
BLIJA LTD

BALANCE SHEET

As at 31 December 2025
BLIJA LTD

BALANCE SHEET (continued)

As at 31 December 2025
Note 2025 2024
£ £
Fixed assets
Tangible assets 3 2,610 1,528
2,610 1,528
Current assets
Debtors 4 44,918 44,023
Cash at bank and in hand 5 114,891 93,794
159,809 137,817
Creditors: amounts falling due within one year 6 ( 31,815) ( 22,825)
Net current assets 127,994 114,992
Total assets less current liabilities 130,604 116,520
Net assets 130,604 116,520
Capital and reserves
Called-up share capital 7 100 100
Profit and loss account 130,504 116,420
Total shareholders' funds 130,604 116,520

For the financial year ending 31 December 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of BLIJA Ltd (registered number: 07107868) were approved and authorised for issue by the Board of Directors on 10 September 2026. They were signed on its behalf by:

Robert Horace Taylor
Director
BLIJA LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 December 2025
BLIJA LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 December 2025
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

BLIJA Ltd (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 36 The Village, Haxby, York, YO32 3HT, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Plant and machinery etc. 4 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Statement of Income and Retained Earnings as described below.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Ordinary share capital

The ordinary share capital of the Company is presented as equity.

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

2. Employees

2025 2024
Number Number
Monthly average number of persons employed by the Company during the year, including directors 2 2

3. Tangible assets

Plant and machinery etc. Total
£ £
Cost
At 01 January 2025 10,601 10,601
Additions 2,057 2,057
At 31 December 2025 12,658 12,658
Accumulated depreciation
At 01 January 2025 9,073 9,073
Charge for the financial year 975 975
At 31 December 2025 10,048 10,048
Net book value
At 31 December 2025 2,610 2,610
At 31 December 2024 1,528 1,528

4. Debtors

2025 2024
£ £
Trade debtors 30,952 29,795
Other debtors 13,966 14,228
44,918 44,023

5. Cash and cash equivalents

2025 2024
£ £
Cash at bank and in hand 114,891 93,794

6. Creditors: amounts falling due within one year

2025 2024
£ £
Taxation and social security 3,437 78
Other creditors 28,378 22,747
31,815 22,825

7. Called-up share capital

2025 2024
£ £
Allotted, called-up and fully-paid
55 Ordinary A shares of £ 1.00 each 55 55
33 Ordinary B shares of £ 1.00 each 33 33
4 Ordinary C shares of £ 1.00 each 4 4
4 Ordinary D shares of £ 1.00 each 4 4
4 Ordinary E shares of £ 1.00 each 4 4
100 100